Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients

Tumor Biology

Volumn 19, Issue 6, 1998, Pages 464-469

  Nakajima, Kazuaki ^a   Ochiai, Takenori ^a   Suzuki, Takao ^a   Shimada, Hideaki ^a   Hayashi, Hideki ^a   Yasumoto, Akihiko ^a   Takeda, Akihiko ^a   Hishikawa, Etsuo ^a   Isono, Kaichi ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alpha fetoprotein; CA 19 9; Carcinoembryonic antigen; Gastric cancer

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

EID: 0031768938     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030038     Document Type: Article

References (18)

1. Posner MR, Mayer RJ: The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994;8:833-853.
2. Kodera Y, Yamamura Y, Tori A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T: The prognostic value of preoperative levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol 1996;91:49-53.
3. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K: Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994;73:2703-2708.
4. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467-481.
5. Hostetter RB, Augustus LB, Mankarious R, Chi KF, Fan D, Toth C, Thomas P, Jessup JM: Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. J Natl Cancer Inst 1990;82:380-385.
6. Hostetter RB, Campbell DE, Chi KF, Kerckhoff S, Cleary KR, Ullrich S, Thomas P, Jessup JM: Carcinoembryonic antigen as a selective enhancer of colorectal carcinoma. Arch Surg 1990;125:300-304.
7. x is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 1991;266:14869-14872.
8. Libman E, Lemberger J, Kollin J: Alpha-fetoprotein in the serum of patients with primary gastric cancer and liver metastases. Acta Hepatogastroenterol 1979;26:198-202.
9. Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, Kimoto T, Nakamura T: Clinico-pathologic features and long-term results of α-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990;85:1480-1485.
10. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma, ed 1. Tokyo, Kanehara, 1995.
11. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics, ed 2. Norwalk, Appleton & Lange, 1994.
12. Cambell MJ, Machin D: Medical Statistics. A Commonsense Approach, ed 2. Chichester, Wiley, 1993.
13. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K: Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection, Surg Oncol 1996;5:133-139.
14. Gonzalez A, Vizoso F, Allende MT, Sanchez MT, Balibrea JL, Ruibal A: Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma. Int J Biol Markers 1996;11:165-171.
15. Kim YH, Ajani JA, Ota DM, Lynch P, Roth JA: Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer 1995;75:451-456.
16. Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A: Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Res 1997;17:2903-2906.
17. Spda A, Roseli M, Cosiraeli M, Ferroni P, Cavaliere FAR, Tedesco M, Carlini S, D'Alessandro R, Perri P, Casciani CU, Greiner JW, Schlom J, Guadagni F: Clinical utility of CA 72-4 serum marker in the staging and immediate postsurgical management of gastric cancer patients, Anticancer Res 1996;16:2241-2247.
18. Ikeguchi M, Katano K, Saitou H, Tsujitani S, Maeta M, Kaibara N: Preoperative serum levels of C A 72-4 in patients with gastric adenocarcinoma. Hepatogastroenterology 1997;44:866-871.